Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
doi:10.1016/S2213-8587(17)30085-2 Rodbard HW, Lingvay I, Reed J, et al
Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)NRG-GI004/SWOG-S1610
The synergistic effects of the glutathione precursor, NAC and first-line antibiotics in the granulomatous response against Mycobacterium tuberculosis
Hormone Optimization Peptide Stacks Fat Loss Protocols FEATURED COURSE PROGRAMS Built Around 25 Years of Real-World Testing Raise Your Vibration A new course Jay & Monica Campbell Raise your vibration
US$ 21.82
US$ 25.15
US$ 23.03
US$ 26.04
US$ 25.77
US$ 24.90
